Pubdiz
Taipei Medical University

Pubdiz from Gene to Disease ��] ��Ʈw

A B C D E F G H I J K L M N O P Q R X Y Z



Gene Symbol
Gene NameAliasesPrevious_Symbol

CHEK2

CHK2 checkpoint homolog (S. pombe)CDS1, CHK2, HuCds1, PP1425, bA444G7CHK2 (checkpoint, S.pombe) homolog


Gene CHEK2 gene interaction
View Neighborhood Gene

Result number fewer <<<< << < ALL > >> >>> more

MeSH term
FrequencyCondition_Probility

Female

220.0

Gene Expression Regulation, Neoplastic

20.0

Genes, BRCA1

42.0

Genes, BRCA2

43.0

Genes, cdc

24.0

Humans

260.0

Immunohistochemistry

40.0

Pedigree

90.0

*Protein-Serine-Threonine Kinases

91.0

Research Support, Non-U.S. Gov't

200.0

Adult

50.0

Aged

50.0

Gene Deletion

20.0

Genetic Predisposition to Disease

70.0

Middle Aged

90.0

Mutation

50.0

Ovarian Neoplasms/*genetics

20.0

Protein-Serine-Threonine Kinases/*genetics

103.0

Research Support, U.S. Gov't, Non-P.H.S.

20.0

Research Support, U.S. Gov't, P.H.S.

30.0

Breast Neoplasms/*genetics

50.0

*Frameshift Mutation

21.0

*Genes, BRCA1

20.0

*Genes, BRCA2

20.0

Genes, Tumor Suppressor

50.0

*Genetic Predisposition to Disease

80.0

Male

110.0

Variation (Genetics)

30.0

Base Sequence

20.0

DNA Mutational Analysis

30.0

*Mutation

20.0

Polymerase Chain Reaction

30.0

Protein-Serine-Threonine Kinases/*genetics/metabolism

23.0

Breast Neoplasms/*etiology/*genetics

222.0

Case-Control Studies

50.0

DNA Damage

30.0

DNA Replication

30.0

*Germ-Line Mutation

71.0

Odds Ratio

30.0

Radiation Tolerance

22.0

Comparative Study

30.0

Risk Factors

40.0

*Sequence Deletion

20.0

Germ-Line Mutation

30.0

Frameshift Mutation

20.0

Loss of Heterozygosity

20.0

DNA, Neoplasm/analysis

20.0

Immunoenzyme Techniques

20.0

Protein Kinases/*genetics

87.0

Breast Neoplasms/enzymology/*genetics

27.0

*Genes, Tumor Suppressor

20.0

Neoplasm Staging

20.0